Research and Development

Israeli-based firm Alcobra is to pull the plug on its experimental attention deficit hyperactivity disorder (ADHD) drug metadoxine after it …

Biogen has announced it is to pay $1.25 billion to Copenhagen-based biotech Forward Pharma in the latest development in a …

A new paper published in the British Medical Journal (BMJ) has called the integrity of certain clinical trials into question …

The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …

After months of uncertainty following the UK’s vote to leave the EU, Theresa May has finally announced the first inklings …

The Centre for Process Innovation is targeting small and medium-sized enterprises from the pharmaceutical and chemical industries with its Innovation …

Merck has teamed up with software and data-mining firm Palantir with the intention to utilise its data analytics services to …

Due to the “strong efficacy” shown by its durvalumab as a treatment for non-small cell lung cancer (NSCLC), AstraZeneca has …

Benzodiazepines and similar drugs could increase the risk of strokes in Alzheimer’s patients by as much as 20% according to …

We’re now into 2017 in earnest and news of acquisitions, partnerships, R&D advancements and scandals are back in force. Cancer …

IBM Watson Health has agreed a research initiative with the FDA to develop and test the exchange of patients’ health …

Takeda has announced its intention to invest $125 million in a partnership with Maverick Therapeutics to develop the latter’s T-cell …

Shire Pharmaceuticals is set to pay a $350 million settlement over accusations that it had bribed clinicians and physicians by …

Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the …

MSD, known as Merck in North America, and Eli Lilly have announced the expansion of their existing immuno-oncology collaboration. The …